Simultaneous assay of Src SH3 and SH2 domain binding using different wavelength fluorescence polarization probes

Analytical Biochemistry

Volumn 275, Issue 1, 1999, Pages 62-73

  Lynch, Berkley A ^a   Minor, Charles ^a   Loiacono, Kara A ^a   Van Schravendijk, Marie Rose ^a   Ram, Mary K ^a   Sundaramoorthi, Raji ^a   Adams, Susan E ^a   Phillips, Tom ^a   Holt, Dennis ^a   Rickles, Richard J ^a   MacNeil, Ian A ^a  

^a ARIAD PHARMACEUTICALS INC   (United States)

Author keywords

Binding assay; Fluorescence polarization; P130(CAS); SH2; SH3; Src

Indexed keywords

AMINO ACIDS; DIAGNOSIS; DISEASES; PEPTIDES; POLARIZATION; PROBES;

BINDING ASSAYS; FLUORESCENCE POLARIZATION; FLUORESCENT PEPTIDES; HIGH THROUGHPUT SCREENING; P130(CAS); PROLINE-RICH SEQUENCES; SIGNALING PATHWAYS; SIMULTANEOUS MEASUREMENT;

FLUORESCENCE;

PROTEIN KINASE P60;

ARTICLE; CANCER; FLUORESCENCE POLARIZATION; OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RADIOASSAY; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

EID: 0033231449     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1006/abio.1999.4305     Document Type: Article

References (28)

1. Thomas S. M., Brugge J. S. Cellular functions regulated by Src family kinases. Annu. Rev. Cell Dev. Biol. 13:1997;513-609.
2. Schwartzberg P. L. The many faces of Src: Multiple functions of a prototypical tyrosine kinase. Oncogene. 17:1998;1463-1468.
3. Pawson T. Protein modules and signaling networks. Nature. 373:1995;573-580.
4. Cohen G. B., Ren R., Baltimore D. Modular binding domains in signal transduction proteins. Cell. 80:1995;237-248.
5. Pawson T., Gish G. D. SH2 and SH3 domains: From structure to function. Cell. 71:1992;359-362.
6. Sakai R., Iwamatsu A., Hirano N., Ogawa S., Tanaka T., Mano H., Yazaki Y., Hirai H. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J. 13:1994;3748-3756.
7. cas related protein, Sin. Genes Dev. 10:1996;1341-1355.
8. Taylor S. J., Anafi M., Pawson T., Shalloway D. Functional interaction between c-Src and is mitotic target, Sam 68. J. Biol. Chem. 270:1995;10120-10124.
9. Jolley M. E. Fluorescence polarization immunoassay for the determination of therapeutic drug levels in human plasma. J. Anal. Toxicol. 5:1981;236.
10. Lynch B. A., Loiacono C. L., Adams S. E., MacNeil I. A. A fluorescence polarization based Src SH2 binding assay. Anal. Biochem. 247:1997;77-82.
11. Wu P., Brasseur M., Schindler U. A high-throughput STAT binding assay using fluorescence polarization. Anal. Biochem. 249:1997;29-36.
12. Cas, a Src homology 3-containing molecule having multiple Src homology 2-binding motifs. J. Biol. Chem. 270:1995;15398-15402.
13. Cas and cortactin accompanies integrin-mediated cell adhesion to extracellular matrix. J. Biol. Chem. 270:1995;22259-22262.
14. Songyang Z., Shoelson S. E., Chaudhuri M., Gish G., Pawson T., Haser W. G., King F., Roberts T., Ratnofsky S., Lechleider R. J., Neel B. G., Birge R. B., Fajardo J. E., Chou M. M., Hanafusa H., Schaffhausen B., Cantley L. C. SH2 domains recognize specific phosphopeptide sequences. Cell. 72:1993;1-20.
15. Johnson K. E., Cameron S., Toda T., Wigler M., Zoller M. J. Expression in Escherichia coli of BCY1, the regulatory subunit of cyclic AMP-dependent protein kinase from Saccharomyces cerevisiae: Purification and characterization. J. Biol. Chem. 262:1987;8636-8642.
16. Gill S. C., von Hippel P. H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182:1989;319-326.
17. Bennett J. P., Yamamura H. I. Yamamura H. I. Neurotransmitter Receptor Binding, 2nd ed. 1985;61-89 Raven Press, New York.
18. Feng S., Chen J. K., Yu H., Simon J. A., Schreiber S. L. Two binding orientations for peptides to the Src SH3 domain: Development of a general model for SH3-ligand interactions. Science. 266:1995;1241-1247.
19. Dalgarno D. C., Botfield M. C., Rickles R. J. SH3 domains and drug design: Ligands, structure, and biological function. Biopolymers. 43:1998;383-400.
20. Feng S., Kasahara C., Rickles R. J., Schreiber S. L. Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands. Proc. Natl. Acad. Sci. USA. 92:1995;12408-12415.
21. Rickles R. J., Botfield M. C., Zhou X.-M., Henry P. A., Brugge P. A., Zoller M. J. Phage display selection of ligand residues important for Src homology 3 domain binding specificity. Proc. Natl. Acad. Sci. USA. 92:1995;10909-10913.
22. Cas to SH2 and SH3 domains of Src Kinase. J. Biol. Chem. 271:1996;8959-8965.
23. Flournoy D. S., Frey P. A. Inactivation of the pyruvate dehydrogenase complex of Escherichia coli by fluoropyruvate. Biochemistry. 28:1989;9594-9602.
24. c-Src SH2 domains: A thermodynamic and structural study. Biochemistry. 36:1997;6283-6293.
25. Alligood K. J., Charifson P., Crosby R., Consler T., Feldman P., Gampe R. T. Jr., Gilmer T., Jordan S., Milstead M., Mohr C., Peel M., Rocque W., Rodriguez M., Rusnak D., Shewchuk L., Sternbach D. The formation of a covalent complex between a dipeptide ligand and the Src SH2 domain. Bioorg. Med. Chem. Lett. 8:1998;1189-1194.
26. Sittampalam G. S., Iversen P. W., Boadt J. A., Kahl S. D., Bright S., Zock J. M., Janzen W. P., Lister M. D. Design of signal windows in high-throughput screening assays for drug discovery. J. Biomol. Screening. 2:1997;159-169.
27. Syk with the gamma and beta subunits of the high-affinity receptor for immunoglobulin E, FceRI. Mol. Cell Biol. 15:1995;272-281.
28. Ottinger E. A., Botfield M. C., Shoelson S. E. Tandem SH2 domains confer high specificity in tyrosine kinase signaling. J. Biol. Chem. 273:1998;729-735.